We report the case of a 52-year-old premenopausal woman diagnosed with de novo HR+, HER2-negative metastatic lobular breast cancer presenting with severe anemia and thrombocytopenia secondary to diffuse bone marrow infiltration. This evidence concerns the gene ERBB2 and anemia (phenotype).